Does intravenous or oral high-dose N-acetylcysteine in addition to saline prevent contrast-induced nephropathy assessed by cystatin C?

Sadeleştirilmiş öğe sayfası
dc.contributor.authorErturk, Mehmet
dc.contributor.authorUslu, Nevzat
dc.contributor.authorGorgulu, Sevket
dc.contributor.authorAkbay, Ertan
dc.contributor.authorKurtulus, Gulsah
dc.contributor.authorAkturk, Ibrahim F.
dc.contributor.authorAkgul, Ozgur
dc.contributor.authorSurgit, Ozgur
dc.contributor.authorUzun, Fatih
dc.contributor.authorGul, Mehmet
dc.contributor.authorIsiksacan, Nilgun
dc.contributor.authorYildirim, Aydin
dc.date.accessioned2025-10-16T15:33:20Z
dc.date.issued2014
dc.identifier.doi10.1097/MCA.0000000000000073
dc.identifier.otherWOS:000331216900006
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/9238
dc.publisherLIPPINCOTT WILLIAMS \& WILKINS
dc.sourceCORONARY ARTERY DISEASE
dc.subjectcontrast media
dc.subjectcystatin C
dc.subjectN\\-acetylcysteine
dc.subjectrenal insufficiency
dc.titleDoes intravenous or oral high-dose N-acetylcysteine in addition to saline prevent contrast-induced nephropathy assessed by cystatin C?
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS